Company Profile
Sera Prognostics Stock Price, News & Analysis
- Ticker:
- SERA
- Exchange:
- NASDAQ
- Sector:
- MedTech
- Location:
- United States
Stock performance
2.00 USD (0.00%)
Close
Last updated: August 6, 2026
79.9M USD
Market cap
Why the stock is moving
As of Aug 6, 2026, SERA was little changed and closed at $2.00. No new same-company headline was identified in the current news window.
Company overview
Business overview
Sera Prognostics is a women's health diagnostics company focused on prenatal testing and pregnancy risk assessment. Its business is centered on biomarker-driven screening rather than therapeutic development.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, Sera sits in medical devices and diagnostics.
Business Model Characteristics
The company depends on test adoption, reimbursement, and the integration of its biomarker platform into clinical care.
Position Within the Biotechnology Landscape
Sera is a diagnostics name whose stock moves on adoption and reimbursement, not drug catalysts.
Future catalysts
Sera Prognostics’ catalysts are PreTRM adoption, reimbursement, and whether the maternal-health diagnostics platform can keep scaling. The company moves when test utilization and coverage both improve.
Recent news
- 01
- 02
- 03
SERA PROGNOSTICS ANNOUNCES APPOINTMENT OF MARK CAPONE TO ITS BOARD OF DIRECTORS
Source: Sera Prognostics
- 04
- 05
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Sera Prognostics (SERA)?
Sera Prognostics (SERA) most recently closed at 2.00 USD, a 0.00% move versus the previous session.
What is the market cap of Sera Prognostics (SERA)?
Sera Prognostics currently has a market capitalization of 79.9M USD on BioPharmSignal.
What does Sera Prognostics do?
Sera Prognostics is a women's health diagnostics company focused on prenatal testing and pregnancy risk assessment. Its business is centered on biomarker-driven screening rather than therapeutic development.
On which exchange is SERA stock listed?
Sera Prognostics (SERA) is associated with NASDAQ, United States, MedTech.
What is Sera?
Sera Prognostics’ catalysts are PreTRM adoption, reimbursement, and whether the maternal-health diagnostics platform can keep scaling.
Which conditions is Sera Prognostics targeting with Sera?
Sera Prognostics’ catalysts are PreTRM adoption, reimbursement, and whether the maternal-health diagnostics platform can keep scaling.
How does Sera Prognostics describe recent progress with Sera?
Sera Prognostics’ catalysts are PreTRM adoption, reimbursement, and whether the maternal-health diagnostics platform can keep scaling.
What is Prognostics?
Sera Prognostics is a women's health diagnostics company focused on prenatal testing and pregnancy risk assessment.